Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 582

1.

Identifying a Neuro-Phenotype in Severe Asthma.

Satia I, O'Byrne PM.

Am J Respir Crit Care Med. 2020 Feb 12. doi: 10.1164/rccm.202002-0228ED. [Epub ahead of print] No abstract available.

PMID:
32049547
2.

Prevalence and contribution of respiratory viruses in the community to rates of emergency department visits and hospitalizations with respiratory tract infections, chronic obstructive pulmonary disease and asthma.

Satia I, Cusack R, Greene JM, O'Byrne PM, Killian KJ, Johnston N.

PLoS One. 2020 Feb 6;15(2):e0228544. doi: 10.1371/journal.pone.0228544. eCollection 2020.

3.

Malignant melanoma of the rectum presenting as cloacogenic polyp: a case report.

Coyne JD, O'Byrne P.

Ann R Coll Surg Engl. 2019 Dec 20:e1-e3. doi: 10.1308/rcsann.2019.0160. [Epub ahead of print]

PMID:
31858824
4.

Perceptions and Experiences of Methadone Maintenance Treatment: A Qualitative Descriptive Research Study.

Jeske CP, O'Byrne P.

J Addict Nurs. 2019 Oct/Dec;30(4):248-253. doi: 10.1097/JAN.0000000000000307.

PMID:
31800515
5.

Use of a vibrating mesh nebulizer for allergen challenge.

Cockcroft DW, Davis BE, Blais CM, Boulet LP, Boulay MÉ, Villeneuve H, Gauvreau GM, O'Byrne PM, Howie KJ, Obminski CD.

Allergy Asthma Clin Immunol. 2019 Nov 26;15:73. doi: 10.1186/s13223-019-0392-8. eCollection 2019.

6.

Active-Offer Nurse-Led PrEP (PrEP-RN) Referrals: Analysis of Uptake Rates and Reasons for Declining.

O'Byrne P, Orser L, Haines M.

AIDS Behav. 2019 Nov 26. doi: 10.1007/s10461-019-02745-9. [Epub ahead of print]

PMID:
31773443
7.

Cholinergic synapse pathway gene polymorphisms associated with allergen-induced late asthmatic responses.

Rajasekaran A, He D, Yue A, Singh A, Shannon CP, FitzGerald JM, Boulet LP, O'Byrne PM, Gauvreau GM, Tebbutt SJ.

ERJ Open Res. 2019 Nov 4;5(4). pii: 00107-2019. doi: 10.1183/23120541.00107-2019. eCollection 2019 Oct.

8.

The presence of Aspergillus fumigatus in asthmatic airways is not clearly related to clinical disease severity.

Sullivan A, Hunt EB, Ward C, Lapthorne S, Eustace JA, Fanning LJ, Plant BJ, O'Byrne PM, MacSharry JA, Murphy DM.

Allergy. 2019 Oct 12. doi: 10.1111/all.14087. [Epub ahead of print]

PMID:
31605638
9.

Avoiding missed opportunities to screen for HIV.

OʼByrne P, Orser L.

J Am Assoc Nurse Pract. 2019 Aug 14. doi: 10.1097/JXX.0000000000000274. [Epub ahead of print]

PMID:
31425375
10.

The Global Initiative for Asthma (GINA): 25 years later.

Boulet LP, Reddel HK, Bateman E, Pedersen S, FitzGerald JM, O'Byrne PM.

Eur Respir J. 2019 Aug 29;54(2). pii: 1900598. doi: 10.1183/13993003.00598-2019. Print 2019 Aug. Review.

PMID:
31273040
11.

Syphilis.

O'Byrne P, MacPherson P.

BMJ. 2019 Jun 28;365:l4159. doi: 10.1136/bmj.l4159. No abstract available. Erratum in: BMJ. 2019 Jul 19;366:l4746.

12.

Effects of interleukin-6 receptor blockade on allergen-induced airway responses in mild asthmatics.

Revez JA, Bain LM, Watson RM, Towers M, Collins T, Killian KJ, O'Byrne PM, Gauvreau GM, Upham JW, Ferreira MA.

Clin Transl Immunology. 2019 Jun 14;8(6):e1044. doi: 10.1002/cti2.1044. eCollection 2019.

13.

The "Side Effects" of HIV PEP Use: Forced Reflections and Introspections on Sexual Decision-Making.

O'Byrne P, Orser L, Jacob JD.

Res Theory Nurs Pract. 2019 May 1;33(2):196-208. doi: 10.1891/1541-6577.33.2.196.

PMID:
31123163
14.
15.

Asthma progression and mortality: the role of inhaled corticosteroids.

O'Byrne P, Fabbri LM, Pavord ID, Papi A, Petruzzelli S, Lange P.

Eur Respir J. 2019 Jul 18;54(1). pii: 1900491. doi: 10.1183/13993003.00491-2019. Print 2019 Jul. Review.

16.

PrEP-RN: Clinical Considerations and Protocols for Nurse-Led PrEP.

OʼByrne P, MacPherson P, Orser L, Jacob JD, Holmes D.

J Assoc Nurses AIDS Care. 2019 May-Jun;30(3):301-311. doi: 10.1097/JNC.0000000000000075.

17.

Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study.

Duong M, Islam S, Rangarajan S, Leong D, Kurmi O, Teo K, Killian K, Dagenais G, Lear S, Wielgosz A, Nair S, Mohan V, Mony P, Gupta R, Kumar R, Rahman O, Yusoff K, du Plessis JL, Igumbor EU, Chifamba J, Li W, Lu Y, Zhi F, Yan R, Iqbal R, Ismail N, Zatonska K, Karsidag K, Rosengren A, Bahonar A, Yusufali A, Lamelas PM, Avezum A, Lopez-Jaramillo P, Lanas F, O'Byrne PM, Yusuf S; PURE investigators.

Lancet Glob Health. 2019 May;7(5):e613-e623. doi: 10.1016/S2214-109X(19)30070-1.

18.

The Evolution of HIV Prevention: From Discipline to Control.

OʼByrne P, Jacob JD.

ANS Adv Nurs Sci. 2019 Oct/Dec;42(4):E1-E10. doi: 10.1097/ANS.0000000000000268.

PMID:
30839336
19.

Fluticasone furoate/vilanterol versus fluticasone propionate in patients with asthma and exercise-induced bronchoconstriction.

Martin N, Weiler JM, Pearlman D, Jacques L, Nunn C, Forth R, West S, Dunn K, O'Byrne PM.

J Asthma. 2019 Feb 22:1-10. doi: 10.1080/02770903.2019.1579344. [Epub ahead of print]

PMID:
30795705
20.

Rigour after gonorrhea treatment in a 55-year-old man.

O'Byrne P.

Can Fam Physician. 2019 Feb;65(2):112-115. No abstract available.

21.

The interleukin-13 paradox in asthma: effective biology, ineffective biologicals.

Nair P, O'Byrne PM.

Eur Respir J. 2019 Jan 31;53(2). pii: 1802250. doi: 10.1183/13993003.02250-2018. Print 2019 Feb. No abstract available.

PMID:
30760544
22.

Effect of sex on group 2 innate lymphoid cells in the airways of mild and severe asthmatics.

Aw M, Nair P, Salter B, Chen R, Machida K, Inman M, O'Byrne PM, Gauvreau GM, Sehmi R.

Allergy. 2019 Jul;74(7):1397-1400. doi: 10.1111/all.13742. Epub 2019 Feb 26. No abstract available.

PMID:
30741429
23.

Recommended screenings for chlamydia and gonorrhea: A Canadian guidelines review.

OʼByrne P.

Nurse Pract. 2019 Feb;44(2):35-41. doi: 10.1097/01.NPR.0000552681.53898.05.

PMID:
30672865
24.

Allergen challenge increases capsaicin-evoked cough responses in patients with allergic asthma.

Satia I, Watson R, Scime T, Dockry RJ, Sen S, Ford JW, Mitchell PD, Fowler SJ, Gauvreau GM, O'Byrne PM, Smith JA.

J Allergy Clin Immunol. 2019 Sep;144(3):788-795.e1. doi: 10.1016/j.jaci.2018.11.050. Epub 2019 Jan 17.

PMID:
30660644
25.

Consideration of sexually transmitted infections in the differential diagnosis: Case studies.

OʼByrne P, MacPherson P, Kitson C, Bourgault A.

J Am Assoc Nurse Pract. 2019 Jan;31(1):65-71. doi: 10.1097/JXX.0000000000000103.

PMID:
30624362
26.

Party Drug Use Among Gay Men: Expanding Contemporary Understandings for Nursing Practice.

O'Byrne P.

Res Theory Nurs Pract. 2018 Aug;32(3):296-310. doi: 10.1891/1541-6577.32.3.296.

PMID:
30567840
27.

Population Health and Social Governance: A Review, an Update, Some Clarifications, and a Response.

O'Byrne P.

Qual Health Res. 2019 Apr;29(5):731-738. doi: 10.1177/1049732318815686. Epub 2018 Dec 14.

PMID:
30547724
28.

Methadone maintenance treatment as social control: Analyzing patient experiences.

O'Byrne P, Jeske Pearson C.

Nurs Inq. 2019 Apr;26(2):e12275. doi: 10.1111/nin.12275. Epub 2018 Nov 20.

PMID:
30460726
29.

The role of public health units in the delivery of HIV pre-exposure prophylaxis (PrEP).

Orser L, O'Byrne P.

Can J Public Health. 2019 Feb;110(1):72-75. doi: 10.17269/s41997-018-0141-7. Epub 2018 Oct 19.

30.

Advances in the treatment of mild asthma: recent evidence.

O'Byrne PM, Mejza F.

Pol Arch Intern Med. 2018 Sep 28;128(9):545-549. doi: 10.20452/pamw.4341. Epub 2018 Sep 28. Review.

31.

An Exploratory Study of a Nurse-Led HIV Postexposure Prophylaxis Program.

O'Byrne P, Jacob JD, Orser L.

Policy Polit Nurs Pract. 2018 Feb-May;19(1-2):29-39. doi: 10.1177/1527154418784237. Epub 2018 Jul 9.

PMID:
29986630
32.

Combined Analysis of Asthma Safety Trials of Long-Acting β2-Agonists.

Busse WW, Bateman ED, Caplan AL, Kelly HW, O'Byrne PM, Rabe KF, Chinchilli VM.

N Engl J Med. 2018 Jun 28;378(26):2497-2505. doi: 10.1056/NEJMoa1716868.

33.

Screening for depression: Review of the Patient Health Questionnaire-9 for nurse practitioners.

OʼByrne P, Jacob JD.

J Am Assoc Nurse Pract. 2018 Jul;30(7):406-411. doi: 10.1097/JXX.0000000000000052.

PMID:
29905589
34.

Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma.

O'Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Ivanov S, Reddel HK.

N Engl J Med. 2018 May 17;378(20):1865-1876. doi: 10.1056/NEJMoa1715274.

35.

As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.

Bateman ED, Reddel HK, O'Byrne PM, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Siwek-Posluszna A, FitzGerald JM.

N Engl J Med. 2018 May 17;378(20):1877-1887. doi: 10.1056/NEJMoa1715275.

36.

Expression of IL-33 and TSLP and Their Receptors in Asthmatic Airways after Inhaled Allergen Challenge.

Al-Sajee D, Sehmi R, Hawke TJ, El-Gammal A, Howie KJ, Watson RM, Londei M, Gauvreau GM, O'Byrne PM.

Am J Respir Crit Care Med. 2018 Sep 15;198(6):805-807. doi: 10.1164/rccm.201712-2468LE. No abstract available.

PMID:
29733677
37.

Two pathways, one patient; UK asthma guidelines.

Fowler SJ, O'Byrne PM, Buhl R, Shaw D.

Thorax. 2018 Sep;73(9):797-798. doi: 10.1136/thoraxjnl-2018-211703. Epub 2018 May 3. No abstract available.

PMID:
29724867
38.

Cucurbit[7]uril-Dimethyllysine Recognition in a Model Protein.

Guagnini F, Antonik PM, Rennie ML, O'Byrne P, Khan AR, Pinalli R, Dalcanale E, Crowley PB.

Angew Chem Int Ed Engl. 2018 Jun 11;57(24):7126-7130. doi: 10.1002/anie.201803232. Epub 2018 May 14.

PMID:
29673020
39.

The patient rationale for seeking HIV PEP: Qualitative results from a nurse-led program.

O'Byrne P, Orser L, MacPherson P, Valela N.

Public Health Nurs. 2018 Sep;35(5):386-395. doi: 10.1111/phn.12404. Epub 2018 Apr 6.

PMID:
29633326
40.

Giants in Chest Medicine: Professor Emeritus Elizabeth F. Juniper, MCSP, MSc.

O'Byrne PM.

Chest. 2018 Apr;153(4):776-777. doi: 10.1016/j.chest.2018.01.017. No abstract available.

PMID:
29626968
41.

Nurse-Led HIV PEP Program Used by Men at High Risk for HIV Seroconversion.

O'Byrne P, MacPherson P, Orser L.

J Assoc Nurses AIDS Care. 2018 Jul - Aug;29(4):550-559. doi: 10.1016/j.jana.2018.02.004. Epub 2018 Feb 17.

PMID:
29530543
42.

Interleukin-25 and eosinophils progenitor cell mobilization in allergic asthma.

Tang W, Smith SG, Du W, Gugilla A, Du J, Oliveria JP, Howie K, Salter BM, Gauvreau GM, O'Byrne PM, Sehmi R.

Clin Transl Allergy. 2018 Feb 13;8:5. doi: 10.1186/s13601-018-0190-2. eCollection 2018.

43.

Evolving Concepts in Asthma.

O'Byrne PM.

Semin Respir Crit Care Med. 2018 Feb;39(1):1-2. doi: 10.1055/s-0037-1620250. Epub 2018 Feb 10. No abstract available.

PMID:
29427979
44.

The effects of a CCR3 inhibitor, AXP1275, on allergen-induced airway responses in adults with mild-to-moderate atopic asthma.

Gauvreau GM, FitzGerald JM, Boulet LP, Watson RM, Hui L, Villineuve H, Scime TX, Schlatman AR, Obminski C, Kum J, Boehme S, Ly TW, Bacon KB, O'Byrne PM.

Clin Exp Allergy. 2018 Apr;48(4):445-451. doi: 10.1111/cea.13114. Epub 2018 Mar 13.

PMID:
29423947
45.

Overfilled urine specimens for gonorrhea and chlamydia testing: Implications for practice.

O'Byrne P, Orser L.

Appl Nurs Res. 2018 Feb;39:121-124. doi: 10.1016/j.apnr.2017.11.014. Epub 2017 Nov 6.

PMID:
29422146
46.

Sputum cytology during late-phase responses to inhalation challenge with different allergens.

Revez JA, Killian KJ, O'Byrne PM, Boulet LP, Upham JW, Gauvreau GM, Ferreira MAR.

Allergy. 2018 Jul;73(7):1470-1478. doi: 10.1111/all.13415. Epub 2018 Feb 6.

PMID:
29337345
47.

Population pharmacokinetics of total and unbound teicoplanin concentrations and dosing simulations in patients with haematological malignancy.

Byrne CJ, Parton T, McWhinney B, Fennell JP, O'Byrne P, Deasy E, Egan S, Enright H, Desmond R, Ryder SA, D'Arcy DM, McHugh J, Roberts JA.

J Antimicrob Chemother. 2018 Apr 1;73(4):995-1003. doi: 10.1093/jac/dkx473.

PMID:
29272419
48.

Changes in regulatory B-cell levels in bone marrow, blood, and sputum of patients with asthma following inhaled allergen challenge.

Oliveria JP, El-Gammal AI, Yee M, Obminski CD, Scime TX, Watson RM, Howie K, O'Byrne PM, Sehmi R, Gauvreau GM.

J Allergy Clin Immunol. 2018 Apr;141(4):1495-1498.e9. doi: 10.1016/j.jaci.2017.11.013. Epub 2017 Dec 6. No abstract available.

49.

Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.

Tan DHS, Hull MW, Yoong D, Tremblay C, O'Byrne P, Thomas R, Kille J, Baril JG, Cox J, Giguere P, Harris M, Hughes C, MacPherson P, O'Donnell S, Reimer J, Singh A, Barrett L, Bogoch I, Jollimore J, Lambert G, Lebouche B, Metz G, Rogers T, Shafran S; Biomedical HIV Prevention Working Group of the CIHR Canadian HIV Trials Network.

CMAJ. 2017 Nov 27;189(47):E1448-E1458. doi: 10.1503/cmaj.170494. No abstract available. Erratum in: CMAJ. 2018 Jun 25;190(25):E782.

50.

Novel Blood-based Transcriptional Biomarker Panels Predict the Late-Phase Asthmatic Response.

Singh A, Shannon CP, Kim YW, Yang CX, Balshaw R, Cohen Freue GV, Gauvreau GM, FitzGerald JM, Boulet LP, O'Byrne PM, Tebbutt SJ.

Am J Respir Crit Care Med. 2018 Feb 15;197(4):450-462. doi: 10.1164/rccm.201701-0110OC.

PMID:
29087730

Supplemental Content

Loading ...
Support Center